Failure of amantadine to modify serum growth hormone and insulin levels
- 1 May 1973
- journal article
- specialia
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 29 (5) , 573
- https://doi.org/10.1007/bf01926672
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- EFFECT OF l-DOPA ADMINISTRATION ON GROWTH HORMONE SECRETION IN NORMAL SUBJECTS AND PARKINSONIAN PATIENTSJournal of Endocrinology, 1972
- Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatmentEuropean Journal of Pharmacology, 1970
- On the mode of action of amantadineJournal of Pharmacy and Pharmacology, 1970
- Amantadine-Dopamine Interaction: Possible Mode of Action in ParkinsonismScience, 1970
- Die Behandlung des Parkinson-Syndroms mit AmantadinDeutsche Medizinische Wochenschrift (1946), 1970
- CONTROLLED TRIAL OF AMANTADINE HYDROCHLORIDE IN PARKINSON'S DISEASEThe Lancet, 1970
- The toxicologic and pharmacologic properties of amantadine hydrochlorideToxicology and Applied Pharmacology, 1969
- Amantadine in the Treatment of Parkinson's DiseaseJAMA, 1969
- Influenza Infections of Mice. I. Curative Activity of Amantadine HCIExperimental Biology and Medicine, 1968
- USE OF GLUCOSE OXIDASE, PEROXIDASE, AND O-DIANISIDINE IN DETERMINATION OF BLOOD AND URINARY GLUCOSEThe Lancet, 1957